Global Cord Blood Corp (CORBF)
| Market Cap | 164.72M |
| Revenue (ttm) | 194.26M |
| Net Income (ttm) | 78.29M |
| Shares Out | n/a |
| EPS (ttm) | 0.57 |
| PE Ratio | 2.16 |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | n/a |
| Open | n/a |
| Previous Close | n/a |
| Day's Range | n/a |
| 52-Week Range | n/a |
| Beta | -0.23 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |
About CORBF
Global Cord Blood Corporation, together with its subsidiaries, provides umbilical cord blood storage and ancillary services in the People's Republic of China. The company offers cord blood testing, processing, and storage services under the direction of subscribers; and tests, processes, and stores donated cord blood, as well as provides matching services. As of March 31, 2022, it operated three cord blood banks, including one in the Beijing municipality; one in the Guangdong province; and one in the Zhejiang province. The company was formerly ... [Read more]
Financial Performance
In 2021, CORBF's revenue was 1.24 billion, an increase of 7.21% compared to the previous year's 1.16 billion. Earnings were 501.07 million, a decrease of -1.41%.
Financial numbers in CNY Financial StatementsNews
IMPORTANT SHAREHOLDER ALERT: The Schall Law Firm Encourages Investors in Global Cord Blood Corporation with Losses to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / May 17, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Global Cord Blood Corporation ("Gl...
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Global Cord Blood Corporation of Class Action Lawsuit and Upcoming Deadlines - CORBF
NEW YORK , May 16, 2024 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Global Cord Blood Corporation ("Global Cord" or the "Company") (OTC: CORBF) and certa...
CORBF Investors Have Opportunity to Lead Global Cord Blood Corporation Securities Fraud Lawsuit
LOS ANGELES , May 15, 2024 /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against ...
ROSEN, NATIONALLY REGARDED INVESTOR COUNSEL, Encourages Global Cord Blood Corporation Investors with Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action - CO, CORBF
NEW YORK , May 13, 2024 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Global Cord Blood Corporation (NYSE: CO) (OTC: CORBF) between June 4...
Class Action Alert: Wolf Haldenstein Adler Freeman & Herz LLP reminds investors that a securities class action lawsuit has been filed in the United States District Court for the Southern District of New York against Global Cord Blood Corporation
Upcoming Lead Plaintiff Deadline is June 21, 2024 NEW YORK , May 10, 2024 /PRNewswire/ -- Wolf Haldenstein Adler Freeman & Herz LLP ("Wolf Haldenstein") announces that a federal securities class acti...
CO Stockholders with Significant Losses Should Contact Robbins LLP for Information About the Global Cord Blood Corporation Securities Class Action
SAN DIEGO--(BUSINESS WIRE)---- $CO #CO--Robbins LLP is Investigating the Allegations that the Board of Global Cord Blood Corporation (CO) Engaged in Self-Serving and Conflicted Transactions.
Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Global Cord Blood Corporation (CORBF)
BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith reminds investors of the upcoming June 24, 2024 deadline to file a lead plaintiff motion in the case filed on behalf of investors who pur...
ROSEN, A LEADING LAW FIRM, Encourages Global Cord Blood Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - CO, CORBF
NEW YORK , May 6, 2024 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Global Cord Blood Corporation (NYSE: CO) (OTC: CORBF) between June 4,...
SHAREHOLDER ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Global Cord
NEW YORK , May 3, 2024 /PRNewswire/ -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Global Cord Blood Corporation ("Global Cord" or the "Comp...
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behalf of Global Cord Blood Corporation (CORBF) Investors
LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, announces that a class action lawsuit has been filed on behalf of investors who purch...
INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Global Cord Blood Corporation (CORBF) Investors
BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Global Cord Blood Corporation (“Global Cord” or...
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Global Cord Blood Corporation (CORBF) on Behalf of Investors
LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Global Cord Blood...
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Global Cord Blood Corporation (CORBF) on Behalf of Investors
BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces an investigation on behalf of Global Cord Blood Corporation (“Global Cord” or the “Company”) (OTC: CORBF) investors concerning ...
ROSEN, A RANKED AND LEADING FIRM, Encourages Global Cord Blood Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action - CO, CORBF
NEW YORK, April 26, 2024 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Global Cord Blo...
Global Cord Blood Corporation (CO) Investor Notice: Robbins LLP Reminds Stockholders of the Global Cord Blood Corporation Class Action
SAN DIEGO--(BUSINESS WIRE)---- $CO #CO--Robbins LLP is Investigating the Allegations that Rivian Automotive, Inc. (RIVN) Misled Investors Regarding Demand for its Products.
ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Global Cord Blood Corporation Investors With Losses in Excess of $100K to Secure Counsel Before Important Deadline in Securities Class Action – CO, CORBF
NEW YORK--(BUSINESS WIRE)--WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Global Cord Blood Corporation...
NYSE to Commence Delisting Proceedings Against Global Cord Blood Corporation (CO)
NEW YORK--(BUSINESS WIRE)--The New York Stock Exchange LLC (“NYSE” or “Exchange”) announced today that the staff of NYSE Regulation has determined to commence proceedings to delist the ordinary shares...
GLOBAL CORD BLOOD CORPORATION ANNOUNCES FAILURE TO FILE INTERIM FINANCIALS
GEORGE TOWN, Cayman Islands and HONG KONG , April 13, 2023 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) (the "Company"), a provider of cord blood collection, laboratory testing, hematopoie...
Global Cord Blood Corporation Announces Appointment of Joint Provisional Liquidators by The Grand Court Of The Cayman Islands
HONG KONG--(BUSINESS WIRE)--Global Cord Blood Corporation (NYSE: CO) (“GCBC” or the “Company”), China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processin...
The Grand Court of the Cayman Islands Granted Blue Ocean's Application to Appoint Joint Provisional Liquidators for Global Cord Blood Corporation
NEW YORK--(BUSINESS WIRE)--Blue Ocean Structure Investment Company Ltd., (“Blue Ocean”) a significant shareholder of Global Cord Blood Corporation (the “Company” or “Global Cord”) (NYSE: CO), today an...
Global Cord Blood Corporation Files Annual Report on Form 20-F
HONG KONG , Aug. 16, 2022 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"), China's leading provider of cord blood collection, laboratory testing, hematopoietic stem ...
Global Cord Blood Corporation Obtained Injunction Order Against Blue Ocean in respect of Purported EGM
HONG KONG , July 6, 2022 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO, "GCBC" or the "Company"), China's leading provider of cord blood collection, laboratory testing, hematopoietic stem ce...
Global Cord Blood Corporation Reports Financial Results for the Fourth Quarter and Full Year of Fiscal 2022
Added 16,423 New Subscribers in 4QFY22 4QFY22 Revenues Down 1.7% YoY to RMB297.2 Million ($46.9 Million) 4QFY22 Gross Profit Down 0.5% YoY to RMB255.2 Million ($40.3 Million) 4QFY22 Operating Income D...
Global Cord Blood Corporation Announced Cellenkos Receives FDA Clearance of IND Application for CK0804 as Add on Therapy to Ruxolitinib for the Treatment of Myelofibrosis
HONG KONG , June 16, 2022 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"), China's leading provider of cord blood collection, laboratory testing, hematopoietic stem ...
Shareholders Led by Blue Ocean Announce Successful Results of Extraordinary General Meeting of Global Cord Blood Corporation
NEW YORK--(BUSINESS WIRE)--Blue Ocean Structure Investment Company Ltd., (“Blue Ocean”) and shareholders representing over 75% of the outstanding shares of Global Cord Blood Corporation (the “Company”...